FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

94111000001105: Comtess 200mg tablets (Orion Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16893701000001111 Comtess 200mg tablets (Orion Pharma (UK) Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
16893801000001119 Comtess 200mg tablets (Orion Pharma (UK) Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Is a Product containing precisely entacapone 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has active ingredient Entacapone false Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Is a Comtess true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has specific active ingredient Entacapone true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Comtess 200mg tablets (Orion Pharma (UK) Ltd) 30 tablet Is pack of False Comtess 200mg tablets (Orion Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) 100 tablet Is pack of False Comtess 200mg tablets (Orion Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) 30 tablet Has AMP True Comtess 200mg tablets (Orion Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Comtess 200mg tablets (Orion Pharma (UK) Ltd) 100 tablet Has AMP True Comtess 200mg tablets (Orion Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start